Page 3 - Patanjali Ayurved

Ramdev, Balkrishna file 'unconditional' apology in Patanjali ad case

The court had also slammed the Central government and asked why it chose to keep its eyes shut when Patanjali claimed that allopathy medicine offered no protection against Covid-19

Lip service, broke every barrier: SC pulls up Ramdev in misleading ad case

The court also came down on the Centre and asked why it 'chose to keep its eyes shut' when Patanjali claimed that allopathy medicine offered no protection against Covid-19

Patanjali misleading ads case: Ramdev tenders apology in Supreme Court

Ramdev submitted an unconditional apology to the Supreme Court, clarifying that Patanjali's intention was solely to encourage healthier living among citizens by promoting the use of its products

Patanjali MD Balkrishna submits apology to SC in misleading ads case

The court had earlier said that Ramdev and Balkrishna were in violation of Section 3 and 4 of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954

Misleading ads case: Patanjali MD Acharya Balkrishna submits apology to SC

In an affidavit submitted to the Supreme Court, Balkrishna apologised for the misleading ads and claimed that the intention of the company was to solely promote Ayurveda

SC asks Ramdev, Balkrishna to appear personally in misleading ads case

The summon followed Patanjali Ayurved and Acharya Balkrishna's failure to respond to a contempt notice of the top court

Misleading ads case: SC orders Ramdev, Balakrishna to appear in person

Patanjali Ayurved has faced scrutiny from the top court for disseminating misleading advertisements that claim to treat medical conditions, a violation of the Magic Remedies Act, 1954

What is the Magic Remedies Act under which Patanjali is facing scrutiny

Everything you need to know on the false advertisement case against Patanjali and the implications of the Drugs and Magic Remedies Act, 1954

Entire country is taken for a ride: SC contempt notice to Patanjali on ads

Misleading ads banned, Centre told to list out steps against false claims

Ramdev under fire: Stop Allopathy vs Ayurveda debate, misleading Ads, SC warns Patanjali

Supreme Court cautions Patanjali Ayurved against making "false" and "misleading" claims in ads. Watch the video to learn more >

Not making false ad, ready for death sentence if found guilty: Patanjali

Baba Ramdev-led Patanjali Ayurved on Wednesday said it was not making any "false advertisements or propaganda" regarding its products, and said it would not object if the Supreme Court were to impose a fine or "even give us a death sentence" if found making misleading claims. A day after the apex court cautioned the company against making "false" and "misleading" claims in advertisements about its medicines as cure of several diseases, Patanjali Ayurved said it has "database with more than one crore people, with real world evidence, preclinical and clinical evidence". "Patanjali have made thousands of people free from several diseases like BP, sugar, thyroid, asthma, arthritis, obesity, liver and kidney failure, and cancer," the company asserted. The company further said, "We humbly respect the Supreme Court of India and if we make false advertisements or propaganda, we would not have any objections if honourable court imposes a fine of crores or even give us a death sentence." On

Patanjali Ayurved to sell 7% stake in its group firm Patanjali Foods

Baba Ramdev-led Patanjali Ayurved Ltd will sell up to 2.53 crore shares in its group firm Patanjali Foods Ltd on stock exchanges in a bid to increase public float to meet listing requirements. The shares of Patanjali Foods, which is into edible oil and other food products, will be offloaded through the Offer For Sale (OFS) route. The floor price has been fixed at Rs 1,000 per equity share for the offer, which will be open on July 13 and 14, according to a regulatory filing by Patanjali Foods on Wednesday. At the floor price, Patanjali Ayurved -- a promoter of Patanjali Foods -- will garner at least Rs 2,530 crore from the share sale. Shares of Patanjali Foods closed marginally higher at Rs 1,228.05 apiece at BSE on Wednesday and its market capitalisation stood at Rs 44,454.78 crore. "Seller (Patanjali Ayurved) proposes to sell up to 25,339,640 equity shares of face value of Rs 2 each of the company (representing 7 per cent of the total paid-up equity share capital of the ...

Five additional brands crossed Rs 100 cr in sales in FY23, says Dabur India

With reduced prices for most of its commodities, Dabur India expects to see expansion in gross margins in the current fiscal; the FMGC major has made an entry into the spices category

Patanjali Foods says not considering FPO to increase public shareholding

But other modes like OFS, QIP to raise public shareholding

Patanjali Foods Q3 profit rises 15% to Rs 269 crore on better sales

Patanjali Foods Ltd, which is mainly into edible oil business, has posted a 15 per cent growth in its net profit to Rs 269.18 crore for the December quarter on better sales. Its net profit stood at Rs 234.07 crore in the year-ago period, according to a regulatory filing. Total income rose by 26 per cent to Rs 7,963.75 crore during the quarter ended December 31, as compared to Rs 6,301.19 crore in the corresponding period of the previous year. During the April-December period of this fiscal, nine-month period ended December 31, 2022, net profit increased to Rs 622.73 crore from Rs 571.87 crore a year ago, said Patanjali Foods, which is part of Baba Ramdev-led Patanjali Ayurved. Total income rose to Rs 23,858.50 crore in the first nine months of this fiscal year from Rs 17,608.18 crore in the previous year. Patanjali Foods Ltd (formerly known as Ruchi Soya Industries Ltd), has 25 manufacturing facilities, and an allocation of 6.23 lakh hectares of oil palm plantation. Besides edibl

Patanjali Foods plans to build export portfolio of FMCG, health products

Firm to focus on new launches with high margins and high growth

Patanjali group eyes Rs 1 trillion turnover over the next 5-7 years

Patanjali also plans to carry out oil palm plantations on over 1.5 mn acres in 55 districts of 11 states, and aims to earn annual returns of Rs 2,000 crore in five to seven years

After Patanjali, Reliance Retail could be the next big disruptor in FMCG

Other FMCG companies will have to increase their advertising spends in segments Reliance makes a meaningful acquisition in order to stay competitive.

Ruchi Soya Industries renamed Patanjali Foods with effect from June 24

In May, Ruchi Soya announced the acquisition of Patanjali Ayurved's entire food business for Rs 690 crore, in order to speed up its transition into an FMCG company

Ruchi Soya acquires Patanjali Ayurved's food business for Rs 690 crore

To pay 1% of turnover of products as annual royalty under transfer agreement